Literature DB >> 10360651

Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.

K Airola1, T Karonen, M Vaalamo, K Lehti, J Lohi, A L Kariniemi, J Keski-Oja, U K Saarialho-Kere.   

Abstract

Since proteolysis of the dermal collagenous matrix and basement membranes is required for local invasive growth and early metastasis formation of cutaneous melanomas, we have analysed the activities/expression levels of certain metalloproteinases in melanomas and cultured melanoma cells by in situ hybridization and Northern analysis. In addition to collagenases-1 and -3 that have been implicated in invasive growth behaviour of various malignant tumours, we analysed the levels of 72-kDa gelatinase and its activators MT1-MMP and TIMP-2 in cultured melanoma cells. The lesions examined included three cases of lentigo maligna and 28 cases of Clark grade I-V melanomas. The premalignant as well as the grade I tumours were consistently negative for collagenase-1 and -3 and TIMP-1 and -3. The collagenases were predominantly expressed in the cancer cells of Clark grade III and IV tumours. TIMP-1 and -3 were abundantly expressed in the cancer and/or stromal cells of grade III and IV melanomas, while TIMP-2 protein was detected also in melanomas representing lower invasive potential. Northern analysis of seven melanoma cell lines showed that the expression of collagenase-1 and TIMPs-1 and -3 was associated with 72-kDa gelatinase positivity. All melanoma cell lines were positive for MT1-MMP and TIMP-2 mRNAs. Our results suggest that overexpression of collagenases-1 and -3 and TIMPs-1 and -3 is induced during melanoma progression. Expression of TIMPs may reflect host response to tumour invasion in an effort to control MMP activity and preserve extracellular matrix integrity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360651      PMCID: PMC2362286          DOI: 10.1038/sj.bjc.6690417

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  54 in total

1.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase.

Authors:  M Höyhtyä; E Hujanen; T Turpeenniemi-Hujanen; U Thorgeirsson; L A Liotta; K Tryggvason
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

3.  Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides.

Authors:  D Iliopoulos; C Ernst; Z Steplewski; J A Jambrosic; U Rodeck; M Herlyn; W H Clark; H Koprowski; D Herlyn
Journal:  J Natl Cancer Inst       Date:  1989-03-15       Impact factor: 13.506

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

6.  Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.

Authors:  U K Saarialho-Kere; S O Kovacs; A P Pentland; J E Olerud; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

Authors:  P D Brown; A T Levy; I M Margulies; L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

8.  Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.

Authors:  J Lohi; I Harvima; J Keski-Oja
Journal:  J Cell Biochem       Date:  1992-12       Impact factor: 4.429

9.  Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma.

Authors:  U K Saarialho-Kere; E S Chang; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.

Authors:  A M Montgomery; Y A De Clerck; K E Langley; R A Reisfeld; B M Mueller
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  49 in total

1.  Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Authors:  Ki-Kyung Jung; Xu-Wen Liu; Rosemarie Chirco; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

2.  Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.

Authors:  Irene Vejgaard Sorensen; Claus Fenger; Henrik Winther; Niels T Foged; Ulrik Lademann; Nils Brünner; Pernille A Usher
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

3.  Angiogenesis and melanoma - from basic science to clinical trials.

Authors:  Maxine Sylvia Emmett; Daemon Dewing; Rowan Oliver Pritchard-Jones
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

4.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

5.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Rian Disci; Sidika Kurul; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.

Authors:  Tomasz Krecicki; Marcin Fraczek; Michal Jelen; Marzena Podhorska; Teresa Szkudlarek; Tomasz Zatonski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-09       Impact factor: 2.503

7.  TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Authors:  Michele B Weiss; Ethan V Abel; Melanie M Mayberry; Kevin J Basile; Adam C Berger; Andrew E Aplin
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

8.  Heparanase mRNA expression and point mutation in hepatocellular carcinoma.

Authors:  Xiao-Peng Chen; Yin-Bib Liu; Jing Rui; Shu-You Peng; Cheng-Hong Peng; Zi-Yan Zhou; Liang-Hui Shi; Hong-Wei Shen; Bin Xu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

9.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

10.  A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Authors:  J S Blackburn; I Liu; C I Coon; C E Brinckerhoff
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.